Hanover Health combines London public affairs and comms practicesHanover Health has restructured its London business, bringing its public affairs and communications practices together. The healthcare communications Share XHanover Health combines London public affairs and comms practiceshttps://pharmaphorum.com/news/hanover-health-alex-davies-emma-gorton/
Iceland’s Sidekick produces national COVID-19 patient trackerThe Iceland-based digital health company Sidekick has adapted its technology to provide remote monitoring, triage and support for Share XIceland’s Sidekick produces national COVID-19 patient trackerhttps://pharmaphorum.com/news/icelands-sidekick-produces-national-covid-19-patient-tracker/
Servier to acquire Danish cancer biotech SymphogenFrance’s Servier has signed a deal to buy the Danish biotech Symphogen, which specialises in antibody-based therapies for Share XServier to acquire Danish cancer biotech Symphogenhttps://pharmaphorum.com/news/servier-to-acquire-danish-biotech-symphogen/
GSK to collaborate with Chinese biotech on COVID-19 vaccineGlaxoSmithKline has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 Share XGSK to collaborate with Chinese biotech on COVID-19 vaccinehttps://pharmaphorum.com/news/gsk-to-collaborate-with-chinese-biotech-on-covid-19-vaccine/
US backs first emergency COVID-19 antibody test from CellexThe FDA has given its first approval to Cellex for a COVID-19 test that can detect whether someone Share XUS backs first emergency COVID-19 antibody test from Cellexhttps://pharmaphorum.com/news/us-backs-first-emergency-covid-19-antibody-test-from-cellex/
Apeiron starts mid-stage trial of drug that blocks coronavirusApeiron Biologics has been cleared to start a European phase 2 trial of a drug that it says Share XApeiron starts mid-stage trial of drug that blocks coronavirushttps://pharmaphorum.com/news/apeiron-starts-mid-stage-trial-of-drug-that-blocks-coronavirus/
Some pharmas acting like “toilet roll profiteers” on COVID-19, says clinicianA leading UK scientist says some drugmakers are acting like “supermarket hoarders” as coronavirus escalates, failing to share Share XSome pharmas acting like “toilet roll profiteers” on COVID-19, says clinicianhttps://pharmaphorum.com/news/some-pharmas-acting-like-toilet-roll-profiteers-on-covid-19-says-clinician/
GSK eyes nasal polyps use for Nucala after trial successGlaxoSmithKline is eyeing another indication for its Nucala (mepolizumab) biologic drug after a phase 3 trial in inflammation Share XGSK eyes nasal polyps use for Nucala after trial successhttps://pharmaphorum.com/news/gsk-eyes-nasal-polyps-use-for-nucala-after-trial-success/
Antitrust delay scuppers Novartis’ $1bn generics sale to AurobindoNovartis has called off the sale of two US generics businesses to India’s Aurobindo Pharma, part of a Share XAntitrust delay scuppers Novartis’ $1bn generics sale to Aurobindohttps://pharmaphorum.com/news/antitrust-delay-scuppers-novartis-1bn-generics-sale-to-aurobindo/
